RK
Rajesh Kumar
About Rajesh Kumar
Data last updated:
Rajesh Kumar is a Director at Pharmestra Biotech Private Limited (since 2024). The companies operate in Paper and Non-Profit Organizations. Pharmestra Biotech Private Limited reported revenue of ₹9 Lakh (FY 2024). Earlier, Rajesh Kumar was a Director at Calvin Institute Of Medical Sciences Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pharmestra Biotech Private Limited U21002DL2023PTC416849 | Director | 07 Oct 2024 | 2023 | ₹9 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Calvin Institute Of Medical Sciences Private Limited U85303BR2024PTC068237 | Director | 11 Mar 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rupam Kumari | 11134802 | Pharmestra Biotech Private Limited | Director |
| Sujata Kumari | 10233540 | Pharmestra Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Kumar
Rajesh Kumar currently holds 1 directorship: Pharmestra Biotech Private Limited (Director, since 07 Oct 2024, revenue ₹9 Lakh (FY 2024)).
Rajesh Kumar was first appointed on 11 Mar 2024 as Director at Calvin Institute Of Medical Sciences Private Limited.
Rajesh Kumar held 1 earlier board appointment: Calvin Institute Of Medical Sciences Private Limited (Director, 11 Mar 2024 to 25 Jul 2025).
The current boards of Rajesh Kumar's companies include Rupam Kumari (Pharmestra Biotech Private Limited), Sujata Kumari (Pharmestra Biotech Private Limited).